prof. dr. E. (Edo) Vellenga



  1. Folkerts, H. (2019). Autophagy in normal hematopoiesis and leukemia: Biological and therapeutic implications. [Groningen]: Rijksuniversiteit Groningen.
  2. Berger, G. (2019). Genetic defects in myeloid malignancies and preleukemic conditions. [Groningen]: Rijksuniversiteit Groningen.
  3. de Waal, E. G. M. (2018). Multiple aspects of a plasma cell dyscrasia. [Groningen]: Rijksuniversiteit Groningen.
  4. Radulovic, V. (2014). The role of epigenetic modifiers in hematopoiesis. [S.l.]: [S.n.].
  5. Jonge-Peeters, S. D. P. W. M. D. (2011). ABC transporters and cholesterol metabolism in acute myeloid leukemia. [S.n.].
  6. Weide, K. V. D. (2011). The use of statins in acute myeloid leukemia. Groningen: s.n.
  7. Louwes, H. (2002). Platelet kinetics in patients with thrombocytopenia. Groningen: s.n.
  8. Kolk, D. M. V. D. (2002). The role of drug effux pumps in acute myeloid leukemia. Groningen: s.n.

ID: 156947